Literature DB >> 26502845

Expression of VEGF and its effect on cell proliferation in patients with chronic myeloid leukemia.

H Chen1, Y-F Shen, F Gong, G-H Yang, Y-Q Jiang, R Zhang.   

Abstract

OBJECTIVE: The aim of this study is to investigate the expression of vascular endothelial growth factor (VEGF) in the serum of patients with chronic myeloid leukemia (CML) and the effect of VEGF on cell proliferation. PATIENTS AND METHODS: Serum VEGF levels in 12 CML patients (7 chronic phase, 5 blast crisis phase) were measured using enzyme linked immunosorbent assay (ELISA). VEGF expression was interfered by transfection of K562 cells. VEGF mRNA levels in transfected K562 cells were determined using RT-PCR and the effect of VEGF on the proliferation of transfected K562 cells was investigated.
RESULTS: VEGF expression levels were significantly higher in CML patients than normal controls and significantly increased during blast crisis phase than during chronic phase. Compared to controls, the proliferation of the K562 cells was suppressed when VEGF expression was inhibited. However, the inhibited proliferation of K562 cells after gene silencing of VEGF was partially abolished after introducing exogenous VEGF into the cells.
CONCLUSIONS: VEGF plays an important role in the initiation and development of CML and monitoring serum VEGF assists guiding the treatment and predicting the prognosis of CML.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26502845

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  VEGFR2-targeted fusion antibody improved NK cell-mediated immunosurveillance against K562 cells.

Authors:  Xueyan Ren; Wei Xie; Youfu Wang; Menghuai Xu; Fang Liu; Mingying Tang; Chenchen Li; Min Wang; Juan Zhang
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

2.  Serum Vascular Endothelial Gowth Factor Correlates with Hasford Score in Chronic Myeloid Leukemia.

Authors:  Mrinalini Kotru; Purvi Mathur; Neha Garg; Yogendar Kumar; Meera Sikka; Usha Rusia
Journal:  Indian J Hematol Blood Transfus       Date:  2021-04-28       Impact factor: 0.900

3.  Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report.

Authors:  Choukri Elm'hadi; Mohamed Reda Khmamouche; Rachid Tanz; Mehdi Toreis; ElMehdi Mahtat; Mohammed Allaoui; Mohammed Oukabli; Nezha Messaoudi; Hassan Errihani; Mohammed Ichou
Journal:  J Med Case Rep       Date:  2017-01-10

Review 4.  Bioactive Phospholipids Enhance Migration and Adhesion of Human Leukemic Cells by Inhibiting Heme Oxygenase 1 (HO-1) and Inducible Nitric Oxygenase Synthase (iNOS) in a p38 MAPK-Dependent Manner.

Authors:  Ahmed Abdelbaset-Ismail; Monika Cymer; Sylwia Borkowska-Rzeszotek; Katarzyna Brzeźniakiewicz-Janus; Pranela Rameshwar; Sham S Kakar; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2019-02       Impact factor: 5.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.